Jelli, B., Taton, O., D’Haene, N., Remmelink, M., & Mekinda, Z. (2021). Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma. European Journal of Case Reports in Internal Medicine, 8(8). https://doi.org/10.12890/2021_002749